nodes	percent_of_prediction	percent_of_DWPC	metapath
Trifluoperazine—HTR2C—choroid plexus—intracranial aneurysm	0.135	0.14	CbGeAlD
Trifluoperazine—HTR2A—choroid plexus—intracranial aneurysm	0.0676	0.0704	CbGeAlD
Trifluoperazine—CALM1—trigeminal nerve—intracranial aneurysm	0.0561	0.0585	CbGeAlD
Trifluoperazine—CALM1—cranial nerve—intracranial aneurysm	0.04	0.0417	CbGeAlD
Trifluoperazine—CALM2—pons—intracranial aneurysm	0.0397	0.0414	CbGeAlD
Trifluoperazine—CALM1—pons—intracranial aneurysm	0.0395	0.0412	CbGeAlD
Trifluoperazine—HTR2A—trigeminal nerve—intracranial aneurysm	0.0342	0.0356	CbGeAlD
Trifluoperazine—HTR2A—vein—intracranial aneurysm	0.0309	0.0322	CbGeAlD
Trifluoperazine—CALY—medulla oblongata—intracranial aneurysm	0.0248	0.0258	CbGeAlD
Trifluoperazine—HTR2A—cranial nerve—intracranial aneurysm	0.0244	0.0254	CbGeAlD
Trifluoperazine—HTR2A—pons—intracranial aneurysm	0.0241	0.0251	CbGeAlD
Trifluoperazine—CALY—midbrain—intracranial aneurysm	0.0227	0.0236	CbGeAlD
Trifluoperazine—S100A4—medulla oblongata—intracranial aneurysm	0.0214	0.0223	CbGeAlD
Trifluoperazine—CALM2—artery—intracranial aneurysm	0.0208	0.0216	CbGeAlD
Trifluoperazine—CALM1—artery—intracranial aneurysm	0.0207	0.0215	CbGeAlD
Trifluoperazine—S100A4—midbrain—intracranial aneurysm	0.0196	0.0204	CbGeAlD
Trifluoperazine—EBPL—cerebellum—intracranial aneurysm	0.0192	0.02	CbGeAlD
Trifluoperazine—CALY—cerebellum—intracranial aneurysm	0.0175	0.0183	CbGeAlD
Trifluoperazine—EBPL—brain—intracranial aneurysm	0.0156	0.0162	CbGeAlD
Trifluoperazine—S100A4—cerebellum—intracranial aneurysm	0.0151	0.0158	CbGeAlD
Trifluoperazine—CALY—brain—intracranial aneurysm	0.0142	0.0148	CbGeAlD
Trifluoperazine—HTR2A—artery—intracranial aneurysm	0.0126	0.0131	CbGeAlD
Trifluoperazine—S100A4—brain—intracranial aneurysm	0.0123	0.0128	CbGeAlD
Trifluoperazine—HTR2C—brainstem—intracranial aneurysm	0.0107	0.0111	CbGeAlD
Trifluoperazine—HTR1A—brainstem—intracranial aneurysm	0.00899	0.00937	CbGeAlD
Trifluoperazine—CALM2—brainstem—intracranial aneurysm	0.00884	0.00921	CbGeAlD
Trifluoperazine—CALM1—brainstem—intracranial aneurysm	0.0088	0.00917	CbGeAlD
Trifluoperazine—ADRA1A—brainstem—intracranial aneurysm	0.00829	0.00864	CbGeAlD
Trifluoperazine—DRD2—brainstem—intracranial aneurysm	0.00813	0.00847	CbGeAlD
Trifluoperazine—CALM3—medulla oblongata—intracranial aneurysm	0.00785	0.00818	CbGeAlD
Trifluoperazine—HTR2C—medulla oblongata—intracranial aneurysm	0.00745	0.00776	CbGeAlD
Trifluoperazine—HTR6—brain—intracranial aneurysm	0.00741	0.00771	CbGeAlD
Trifluoperazine—CALM3—midbrain—intracranial aneurysm	0.00717	0.00747	CbGeAlD
Trifluoperazine—SIGMAR1—medulla oblongata—intracranial aneurysm	0.00702	0.00731	CbGeAlD
Trifluoperazine—HTR2C—midbrain—intracranial aneurysm	0.00681	0.00709	CbGeAlD
Trifluoperazine—SIGMAR1—midbrain—intracranial aneurysm	0.00641	0.00668	CbGeAlD
Trifluoperazine—CALM2—medulla oblongata—intracranial aneurysm	0.00616	0.00642	CbGeAlD
Trifluoperazine—CALM1—medulla oblongata—intracranial aneurysm	0.00614	0.00639	CbGeAlD
Trifluoperazine—HTR1A—midbrain—intracranial aneurysm	0.00573	0.00597	CbGeAlD
Trifluoperazine—CALM2—midbrain—intracranial aneurysm	0.00563	0.00587	CbGeAlD
Trifluoperazine—CALM1—midbrain—intracranial aneurysm	0.00561	0.00584	CbGeAlD
Trifluoperazine—CALM3—cerebellum—intracranial aneurysm	0.00555	0.00578	CbGeAlD
Trifluoperazine—HTR2A—brainstem—intracranial aneurysm	0.00536	0.00558	CbGeAlD
Trifluoperazine—DRD2—midbrain—intracranial aneurysm	0.00518	0.00539	CbGeAlD
Trifluoperazine—SIGMAR1—cerebellum—intracranial aneurysm	0.00496	0.00517	CbGeAlD
Trifluoperazine—CALM3—brain—intracranial aneurysm	0.00451	0.0047	CbGeAlD
Trifluoperazine—CHRM2—brain—intracranial aneurysm	0.00444	0.00462	CbGeAlD
Trifluoperazine—HTR1A—cerebellum—intracranial aneurysm	0.00443	0.00462	CbGeAlD
Trifluoperazine—CALM2—cerebellum—intracranial aneurysm	0.00436	0.00454	CbGeAlD
Trifluoperazine—CALM1—cerebellum—intracranial aneurysm	0.00434	0.00452	CbGeAlD
Trifluoperazine—HTR2C—brain—intracranial aneurysm	0.00428	0.00446	CbGeAlD
Trifluoperazine—ADRA1A—cerebellum—intracranial aneurysm	0.00409	0.00426	CbGeAlD
Trifluoperazine—SIGMAR1—brain—intracranial aneurysm	0.00403	0.0042	CbGeAlD
Trifluoperazine—DRD2—cerebellum—intracranial aneurysm	0.00401	0.00417	CbGeAlD
Trifluoperazine—HTR2A—medulla oblongata—intracranial aneurysm	0.00374	0.00389	CbGeAlD
Trifluoperazine—HTR1A—brain—intracranial aneurysm	0.0036	0.00375	CbGeAlD
Trifluoperazine—CALM2—brain—intracranial aneurysm	0.00354	0.00369	CbGeAlD
Trifluoperazine—CALM1—brain—intracranial aneurysm	0.00352	0.00367	CbGeAlD
Trifluoperazine—HTR2A—midbrain—intracranial aneurysm	0.00342	0.00356	CbGeAlD
Trifluoperazine—ADRA1A—brain—intracranial aneurysm	0.00332	0.00346	CbGeAlD
Trifluoperazine—DRD2—brain—intracranial aneurysm	0.00325	0.00339	CbGeAlD
Trifluoperazine—HTR2A—cerebellum—intracranial aneurysm	0.00264	0.00275	CbGeAlD
Trifluoperazine—HRH1—brain—intracranial aneurysm	0.00257	0.00268	CbGeAlD
Trifluoperazine—ABCB1—medulla oblongata—intracranial aneurysm	0.00245	0.00255	CbGeAlD
Trifluoperazine—ABCB1—midbrain—intracranial aneurysm	0.00224	0.00233	CbGeAlD
Trifluoperazine—HTR2A—brain—intracranial aneurysm	0.00215	0.00224	CbGeAlD
Trifluoperazine—ABCB1—cerebellum—intracranial aneurysm	0.00173	0.0018	CbGeAlD
Trifluoperazine—ABCB1—brain—intracranial aneurysm	0.00141	0.00147	CbGeAlD
Trifluoperazine—CALM2—Endothelin Pathways—NOS3—intracranial aneurysm	0.0003	0.0075	CbGpPWpGaD
Trifluoperazine—XDH—Metabolism—SLC25A16—intracranial aneurysm	0.000295	0.00737	CbGpPWpGaD
Trifluoperazine—UGT1A4—Metabolism—SLC25A16—intracranial aneurysm	0.000295	0.00737	CbGpPWpGaD
Trifluoperazine—CALM3—VEGFA-VEGFR2 Pathway—NCF1—intracranial aneurysm	0.000292	0.0073	CbGpPWpGaD
Trifluoperazine—CALM2—VEGFA-VEGFR2 Pathway—NCF1—intracranial aneurysm	0.000282	0.00706	CbGpPWpGaD
Trifluoperazine—CALM1—VEGFA-VEGFR2 Pathway—NCF1—intracranial aneurysm	0.000282	0.00706	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by VEGF—NCF1—intracranial aneurysm	0.000275	0.00689	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by VEGF—NCF1—intracranial aneurysm	0.000266	0.00666	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by VEGF—NCF1—intracranial aneurysm	0.000266	0.00666	CbGpPWpGaD
Trifluoperazine—HTR6—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.000257	0.00642	CbGpPWpGaD
Trifluoperazine—DRD2—Circadian rythm related genes—CST3—intracranial aneurysm	0.000248	0.0062	CbGpPWpGaD
Trifluoperazine—HTR2C—G alpha (q) signalling events—EDNRA—intracranial aneurysm	0.000244	0.00612	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—STARD13—intracranial aneurysm	0.000233	0.00582	CbGpPWpGaD
Trifluoperazine—HTR6—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.00022	0.0055	CbGpPWpGaD
Trifluoperazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—intracranial aneurysm	0.000219	0.00547	CbGpPWpGaD
Trifluoperazine—HTR2A—G alpha (q) signalling events—EDNRA—intracranial aneurysm	0.000212	0.00531	CbGpPWpGaD
Trifluoperazine—HRH1—G alpha (q) signalling events—EDNRA—intracranial aneurysm	0.000212	0.0053	CbGpPWpGaD
Trifluoperazine—ADRA1A—G alpha (q) signalling events—EDNRA—intracranial aneurysm	0.000208	0.0052	CbGpPWpGaD
Trifluoperazine—UGT1A4—Metabolism—ASAH1—intracranial aneurysm	0.000195	0.00488	CbGpPWpGaD
Trifluoperazine—XDH—Metabolism—ASAH1—intracranial aneurysm	0.000195	0.00488	CbGpPWpGaD
Trifluoperazine—HTR1A—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.00019	0.00475	CbGpPWpGaD
Trifluoperazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—intracranial aneurysm	0.00019	0.00475	CbGpPWpGaD
Trifluoperazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—intracranial aneurysm	0.000189	0.00474	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.000189	0.00473	CbGpPWpGaD
Trifluoperazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—intracranial aneurysm	0.000186	0.00465	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling events mediated by VEGFR1 and VEGFR2—NOS3—intracranial aneurysm	0.000174	0.00435	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—STARD13—intracranial aneurysm	0.000172	0.00431	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—STARD13—intracranial aneurysm	0.000171	0.00429	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling events mediated by VEGFR1 and VEGFR2—NOS3—intracranial aneurysm	0.000168	0.00421	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling events mediated by VEGFR1 and VEGFR2—NOS3—intracranial aneurysm	0.000168	0.00421	CbGpPWpGaD
Trifluoperazine—HTR6—GPCR ligand binding—EDNRA—intracranial aneurysm	0.000167	0.00419	CbGpPWpGaD
Trifluoperazine—DRD2—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.000167	0.00417	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.000164	0.0041	CbGpPWpGaD
Trifluoperazine—HRH1—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.000164	0.0041	CbGpPWpGaD
Trifluoperazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.000163	0.00407	CbGpPWpGaD
Trifluoperazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.000162	0.00405	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.000161	0.00403	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.000161	0.00402	CbGpPWpGaD
Trifluoperazine—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—intracranial aneurysm	0.00016	0.004	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—STARD13—intracranial aneurysm	0.000151	0.00378	CbGpPWpGaD
Trifluoperazine—CALM3—Platelet activation, signaling and aggregation—TIMP1—intracranial aneurysm	0.00015	0.00376	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—STARD13—intracranial aneurysm	0.000149	0.00372	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—STARD13—intracranial aneurysm	0.000148	0.00371	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—STARD13—intracranial aneurysm	0.000146	0.00365	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—STARD13—intracranial aneurysm	0.000146	0.00364	CbGpPWpGaD
Trifluoperazine—CALM1—Platelet activation, signaling and aggregation—TIMP1—intracranial aneurysm	0.000145	0.00364	CbGpPWpGaD
Trifluoperazine—CALM2—Platelet activation, signaling and aggregation—TIMP1—intracranial aneurysm	0.000145	0.00364	CbGpPWpGaD
Trifluoperazine—DRD2—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.000143	0.00357	CbGpPWpGaD
Trifluoperazine—CALM2—Endochondral Ossification—MMP9—intracranial aneurysm	0.000142	0.00354	CbGpPWpGaD
Trifluoperazine—CALM1—Endochondral Ossification—MMP9—intracranial aneurysm	0.000142	0.00354	CbGpPWpGaD
Trifluoperazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.000141	0.00352	CbGpPWpGaD
Trifluoperazine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.00014	0.00351	CbGpPWpGaD
Trifluoperazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.000138	0.00345	CbGpPWpGaD
Trifluoperazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.000138	0.00344	CbGpPWpGaD
Trifluoperazine—HTR1A—GPCR ligand binding—EDNRA—intracranial aneurysm	0.000124	0.0031	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—STARD13—intracranial aneurysm	0.000124	0.00309	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCR ligand binding—EDNRA—intracranial aneurysm	0.000123	0.00308	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—SLC25A16—intracranial aneurysm	0.000122	0.00306	CbGpPWpGaD
Trifluoperazine—CALM3—VEGFA-VEGFR2 Pathway—NOS3—intracranial aneurysm	0.000121	0.00303	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—STARD13—intracranial aneurysm	0.000119	0.00299	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—STARD13—intracranial aneurysm	0.000119	0.00299	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—SLC25A16—intracranial aneurysm	0.000118	0.00296	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—SLC25A16—intracranial aneurysm	0.000118	0.00296	CbGpPWpGaD
Trifluoperazine—CALM2—VEGFA-VEGFR2 Pathway—NOS3—intracranial aneurysm	0.000117	0.00293	CbGpPWpGaD
Trifluoperazine—CALM1—VEGFA-VEGFR2 Pathway—NOS3—intracranial aneurysm	0.000117	0.00293	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by VEGF—NOS3—intracranial aneurysm	0.000114	0.00286	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by VEGF—NOS3—intracranial aneurysm	0.00011	0.00276	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by VEGF—NOS3—intracranial aneurysm	0.00011	0.00276	CbGpPWpGaD
Trifluoperazine—DRD2—GPCR ligand binding—EDNRA—intracranial aneurysm	0.000109	0.00272	CbGpPWpGaD
Trifluoperazine—HTR6—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.000108	0.00271	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCR ligand binding—EDNRA—intracranial aneurysm	0.000107	0.00268	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR ligand binding—EDNRA—intracranial aneurysm	0.000107	0.00267	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR ligand binding—EDNRA—intracranial aneurysm	0.000105	0.00263	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR ligand binding—EDNRA—intracranial aneurysm	0.000105	0.00262	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—SLC25A16—intracranial aneurysm	0.000102	0.00256	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—CTSS—intracranial aneurysm	0.0001	0.0025	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—SLC25A16—intracranial aneurysm	9.9e-05	0.00248	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—SLC25A16—intracranial aneurysm	9.9e-05	0.00248	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—CTSS—intracranial aneurysm	9.67e-05	0.00242	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—CTSS—intracranial aneurysm	9.67e-05	0.00242	CbGpPWpGaD
Trifluoperazine—CALM3—Adaptive Immune System—CTSS—intracranial aneurysm	9.6e-05	0.0024	CbGpPWpGaD
Trifluoperazine—HTR6—GPCR downstream signaling—EDNRA—intracranial aneurysm	9.46e-05	0.00237	CbGpPWpGaD
Trifluoperazine—CALM2—Adaptive Immune System—CTSS—intracranial aneurysm	9.29e-05	0.00232	CbGpPWpGaD
Trifluoperazine—CALM1—Adaptive Immune System—CTSS—intracranial aneurysm	9.29e-05	0.00232	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	9.21e-05	0.0023	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—CTSK—intracranial aneurysm	9.2e-05	0.0023	CbGpPWpGaD
Trifluoperazine—CALM3—Myometrial Relaxation and Contraction Pathways—NOS3—intracranial aneurysm	8.99e-05	0.00225	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—CTSK—intracranial aneurysm	8.9e-05	0.00223	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—CTSK—intracranial aneurysm	8.9e-05	0.00223	CbGpPWpGaD
Trifluoperazine—CALM3—Adaptive Immune System—CTSK—intracranial aneurysm	8.83e-05	0.00221	CbGpPWpGaD
Trifluoperazine—CALM1—Myometrial Relaxation and Contraction Pathways—NOS3—intracranial aneurysm	8.7e-05	0.00218	CbGpPWpGaD
Trifluoperazine—CALM2—Myometrial Relaxation and Contraction Pathways—NOS3—intracranial aneurysm	8.7e-05	0.00218	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling by GPCR—EDNRA—intracranial aneurysm	8.59e-05	0.00215	CbGpPWpGaD
Trifluoperazine—CALM1—Adaptive Immune System—CTSK—intracranial aneurysm	8.55e-05	0.00214	CbGpPWpGaD
Trifluoperazine—CALM2—Adaptive Immune System—CTSK—intracranial aneurysm	8.55e-05	0.00214	CbGpPWpGaD
Trifluoperazine—HTR6—GPCR ligand binding—CCL2—intracranial aneurysm	8.25e-05	0.00206	CbGpPWpGaD
Trifluoperazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	8.02e-05	0.00201	CbGpPWpGaD
Trifluoperazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	7.98e-05	0.002	CbGpPWpGaD
Trifluoperazine—EBP—Metabolism—NOS3—intracranial aneurysm	7.9e-05	0.00198	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—SLC25A16—intracranial aneurysm	7.76e-05	0.00194	CbGpPWpGaD
Trifluoperazine—CALM3—Hemostasis—TIMP1—intracranial aneurysm	7.74e-05	0.00194	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—CTSB—intracranial aneurysm	7.62e-05	0.00191	CbGpPWpGaD
Trifluoperazine—CALM2—Hemostasis—TIMP1—intracranial aneurysm	7.49e-05	0.00187	CbGpPWpGaD
Trifluoperazine—CALM1—Hemostasis—TIMP1—intracranial aneurysm	7.49e-05	0.00187	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—CTSB—intracranial aneurysm	7.37e-05	0.00184	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—CTSB—intracranial aneurysm	7.37e-05	0.00184	CbGpPWpGaD
Trifluoperazine—CALM3—Adaptive Immune System—CTSB—intracranial aneurysm	7.31e-05	0.00183	CbGpPWpGaD
Trifluoperazine—CALM3—Adaptive Immune System—NCF1—intracranial aneurysm	7.28e-05	0.00182	CbGpPWpGaD
Trifluoperazine—CALM1—Adaptive Immune System—CTSB—intracranial aneurysm	7.07e-05	0.00177	CbGpPWpGaD
Trifluoperazine—CALM2—Adaptive Immune System—CTSB—intracranial aneurysm	7.07e-05	0.00177	CbGpPWpGaD
Trifluoperazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	7.04e-05	0.00176	CbGpPWpGaD
Trifluoperazine—CALM2—Adaptive Immune System—NCF1—intracranial aneurysm	7.04e-05	0.00176	CbGpPWpGaD
Trifluoperazine—CALM1—Adaptive Immune System—NCF1—intracranial aneurysm	7.04e-05	0.00176	CbGpPWpGaD
Trifluoperazine—HTR1A—GPCR downstream signaling—EDNRA—intracranial aneurysm	7e-05	0.00175	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCR downstream signaling—EDNRA—intracranial aneurysm	6.97e-05	0.00174	CbGpPWpGaD
Trifluoperazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	6.93e-05	0.00173	CbGpPWpGaD
Trifluoperazine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	6.91e-05	0.00173	CbGpPWpGaD
Trifluoperazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	6.8e-05	0.0017	CbGpPWpGaD
Trifluoperazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	6.78e-05	0.0017	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—ASAH1—intracranial aneurysm	6.78e-05	0.0017	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—ASAH1—intracranial aneurysm	6.56e-05	0.00164	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—ASAH1—intracranial aneurysm	6.56e-05	0.00164	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—EDNRA—intracranial aneurysm	6.36e-05	0.00159	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—EDNRA—intracranial aneurysm	6.33e-05	0.00158	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—SLC25A16—intracranial aneurysm	6.19e-05	0.00155	CbGpPWpGaD
Trifluoperazine—DRD2—GPCR downstream signaling—EDNRA—intracranial aneurysm	6.15e-05	0.00154	CbGpPWpGaD
Trifluoperazine—HTR1A—GPCR ligand binding—CCL2—intracranial aneurysm	6.11e-05	0.00153	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCR ligand binding—CCL2—intracranial aneurysm	6.08e-05	0.00152	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCR downstream signaling—EDNRA—intracranial aneurysm	6.05e-05	0.00151	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR downstream signaling—EDNRA—intracranial aneurysm	6.04e-05	0.00151	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR downstream signaling—EDNRA—intracranial aneurysm	5.94e-05	0.00149	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR downstream signaling—EDNRA—intracranial aneurysm	5.92e-05	0.00148	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—CTSS—intracranial aneurysm	5.82e-05	0.00146	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—CTSS—intracranial aneurysm	5.63e-05	0.00141	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—CTSS—intracranial aneurysm	5.63e-05	0.00141	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—EDNRA—intracranial aneurysm	5.58e-05	0.0014	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—EDNRA—intracranial aneurysm	5.49e-05	0.00137	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—EDNRA—intracranial aneurysm	5.48e-05	0.00137	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—EDNRA—intracranial aneurysm	5.39e-05	0.00135	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—EDNRA—intracranial aneurysm	5.38e-05	0.00135	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—NCF1—intracranial aneurysm	5.37e-05	0.00134	CbGpPWpGaD
Trifluoperazine—DRD2—GPCR ligand binding—CCL2—intracranial aneurysm	5.36e-05	0.00134	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—CTSK—intracranial aneurysm	5.36e-05	0.00134	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCR ligand binding—CCL2—intracranial aneurysm	5.28e-05	0.00132	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR ligand binding—CCL2—intracranial aneurysm	5.26e-05	0.00132	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—CTSK—intracranial aneurysm	5.18e-05	0.0013	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—CTSK—intracranial aneurysm	5.18e-05	0.0013	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR ligand binding—CCL2—intracranial aneurysm	5.18e-05	0.0013	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR ligand binding—CCL2—intracranial aneurysm	5.17e-05	0.00129	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—ASAH1—intracranial aneurysm	5.14e-05	0.00129	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—EDNRA—intracranial aneurysm	5.08e-05	0.00127	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—AGER—intracranial aneurysm	4.92e-05	0.00123	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—AGER—intracranial aneurysm	4.76e-05	0.00119	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—AGER—intracranial aneurysm	4.76e-05	0.00119	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—CST3—intracranial aneurysm	4.69e-05	0.00117	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—EDNRA—intracranial aneurysm	4.56e-05	0.00114	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—CST3—intracranial aneurysm	4.53e-05	0.00113	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—CST3—intracranial aneurysm	4.53e-05	0.00113	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—CTSB—intracranial aneurysm	4.44e-05	0.00111	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—NCF1—intracranial aneurysm	4.41e-05	0.0011	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—EDNRA—intracranial aneurysm	4.41e-05	0.0011	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—EDNRA—intracranial aneurysm	4.41e-05	0.0011	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—CTSB—intracranial aneurysm	4.29e-05	0.00107	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—CTSB—intracranial aneurysm	4.29e-05	0.00107	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—NCF1—intracranial aneurysm	4.27e-05	0.00107	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—NCF1—intracranial aneurysm	4.27e-05	0.00107	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling by GPCR—CCL2—intracranial aneurysm	4.23e-05	0.00106	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—ASAH1—intracranial aneurysm	4.1e-05	0.00103	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—NCF1—intracranial aneurysm	4.07e-05	0.00102	CbGpPWpGaD
Trifluoperazine—XDH—Metabolism—NOS3—intracranial aneurysm	4.07e-05	0.00102	CbGpPWpGaD
Trifluoperazine—UGT1A4—Metabolism—NOS3—intracranial aneurysm	4.07e-05	0.00102	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—NCF1—intracranial aneurysm	3.98e-05	0.000995	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—NCF1—intracranial aneurysm	3.96e-05	0.00099	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—NCF1—intracranial aneurysm	3.94e-05	0.000986	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—NCF1—intracranial aneurysm	3.94e-05	0.000986	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—EDNRA—intracranial aneurysm	3.76e-05	0.00094	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—EDNRA—intracranial aneurysm	3.74e-05	0.000935	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—NCF1—intracranial aneurysm	3.49e-05	0.000874	CbGpPWpGaD
Trifluoperazine—CALM3—Hemostasis—NOS3—intracranial aneurysm	3.49e-05	0.000873	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—NCF1—intracranial aneurysm	3.44e-05	0.00086	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—NCF1—intracranial aneurysm	3.43e-05	0.000858	CbGpPWpGaD
Trifluoperazine—CALM2—Hemostasis—NOS3—intracranial aneurysm	3.38e-05	0.000845	CbGpPWpGaD
Trifluoperazine—CALM1—Hemostasis—NOS3—intracranial aneurysm	3.38e-05	0.000845	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—NCF1—intracranial aneurysm	3.37e-05	0.000844	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—NCF1—intracranial aneurysm	3.37e-05	0.000842	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—EDNRA—intracranial aneurysm	3.3e-05	0.000825	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—EDNRA—intracranial aneurysm	3.25e-05	0.000812	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—EDNRA—intracranial aneurysm	3.24e-05	0.00081	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—EDNRA—intracranial aneurysm	3.19e-05	0.000797	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—EDNRA—intracranial aneurysm	3.18e-05	0.000795	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—CCL2—intracranial aneurysm	3.13e-05	0.000784	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—CCL2—intracranial aneurysm	3.12e-05	0.00078	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—AGER—intracranial aneurysm	2.86e-05	0.000716	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—NCF1—intracranial aneurysm	2.85e-05	0.000714	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—AGER—intracranial aneurysm	2.77e-05	0.000693	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—AGER—intracranial aneurysm	2.77e-05	0.000693	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—NCF1—intracranial aneurysm	2.76e-05	0.00069	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—NCF1—intracranial aneurysm	2.76e-05	0.00069	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—CCL2—intracranial aneurysm	2.75e-05	0.000688	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—CCL2—intracranial aneurysm	2.71e-05	0.000677	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—CCL2—intracranial aneurysm	2.7e-05	0.000676	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—EDNRA—intracranial aneurysm	2.69e-05	0.000674	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—CCL2—intracranial aneurysm	2.66e-05	0.000665	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—CCL2—intracranial aneurysm	2.65e-05	0.000663	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—EDNRA—intracranial aneurysm	2.61e-05	0.000652	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—EDNRA—intracranial aneurysm	2.61e-05	0.000652	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—CCL2—intracranial aneurysm	2.5e-05	0.000626	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—CCL2—intracranial aneurysm	2.25e-05	0.000562	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—NOS3—intracranial aneurysm	2.23e-05	0.000558	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—CCL2—intracranial aneurysm	2.17e-05	0.000544	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—CCL2—intracranial aneurysm	2.17e-05	0.000544	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—CCL2—intracranial aneurysm	1.85e-05	0.000463	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—CCL2—intracranial aneurysm	1.84e-05	0.000461	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—MMP9—intracranial aneurysm	1.79e-05	0.000447	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—NOS3—intracranial aneurysm	1.69e-05	0.000423	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—NOS3—intracranial aneurysm	1.65e-05	0.000413	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—NOS3—intracranial aneurysm	1.64e-05	0.000411	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—NOS3—intracranial aneurysm	1.63e-05	0.000409	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—NOS3—intracranial aneurysm	1.63e-05	0.000409	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CCL2—intracranial aneurysm	1.63e-05	0.000407	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CCL2—intracranial aneurysm	1.6e-05	0.0004	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CCL2—intracranial aneurysm	1.6e-05	0.000399	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CCL2—intracranial aneurysm	1.57e-05	0.000393	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CCL2—intracranial aneurysm	1.57e-05	0.000392	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—NOS3—intracranial aneurysm	1.45e-05	0.000362	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—NOS3—intracranial aneurysm	1.43e-05	0.000357	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—NOS3—intracranial aneurysm	1.42e-05	0.000356	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—NOS3—intracranial aneurysm	1.42e-05	0.000354	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—NOS3—intracranial aneurysm	1.4e-05	0.00035	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—NOS3—intracranial aneurysm	1.4e-05	0.000349	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—NOS3—intracranial aneurysm	1.37e-05	0.000342	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—NOS3—intracranial aneurysm	1.37e-05	0.000342	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CCL2—intracranial aneurysm	1.33e-05	0.000332	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—MMP9—intracranial aneurysm	1.32e-05	0.000331	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—MMP9—intracranial aneurysm	1.32e-05	0.000329	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CCL2—intracranial aneurysm	1.28e-05	0.000321	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CCL2—intracranial aneurysm	1.28e-05	0.000321	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—NOS3—intracranial aneurysm	1.18e-05	0.000296	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—MMP9—intracranial aneurysm	1.16e-05	0.000291	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—NOS3—intracranial aneurysm	1.14e-05	0.000286	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—NOS3—intracranial aneurysm	1.14e-05	0.000286	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—MMP9—intracranial aneurysm	1.14e-05	0.000286	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—MMP9—intracranial aneurysm	1.14e-05	0.000285	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—MMP9—intracranial aneurysm	1.12e-05	0.000281	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—MMP9—intracranial aneurysm	1.12e-05	0.00028	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—NOS3—intracranial aneurysm	1.07e-05	0.000268	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MMP9—intracranial aneurysm	9.49e-06	0.000237	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MMP9—intracranial aneurysm	9.18e-06	0.00023	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MMP9—intracranial aneurysm	9.18e-06	0.00023	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—NOS3—intracranial aneurysm	8.56e-06	0.000214	CbGpPWpGaD
